Abstract
To investigate the cardioprotective effects and mechanism of action of KR-32560 {[5-(2-methoxy-5-fluorophenyl)furan-2-ylcarbonyl]guanidine}, a newly synthesized NHE-1 inhibitor, we evaluated the effects of KR-32560 on cardiac function in a rat model of ischemia/reperfusion (I/R)-induced heart injury as well as the role antioxidant enzymes and pro-survival proteins play these observed effects. In isolated rat hearts subjected to 25 min of global ischemia followed by 30 min of reperfusion, KR-32560 (3 and 10 μM) significantly reversed the I/Rinduced decrease in left ventricular developed pressure and increase in left ventricular enddiastolic pressure. In rat hearts reperfused for 30 min, KR-32560 (10 μM) significantly decreased the malondialdehyde content while increasing the activities of both glutathione peroxidase and catalase, two important antioxidant enzymes. Western blotting analysis of left ventricles subjected to I/R showed that KR-32560 significantly increased phosphorylation of both Akt and GSK-3β in a dose-dependent manner, with no effect on the phosphorylation of eNOS. These results suggest that KR-32560 exerts potent cardioprotective effects against I/Rinduced rat heart injury and that its mechanism involves antioxidant enzymes and the Akt-GSK-3β cell survival pathway.
Similar content being viewed by others
References
Aebi, H., Wyss, S. R., Scherz, B., and Skvaril, F., Heterogeneity of erythrocyte catalase II. Isolation and characterization of normal and variant erythrocyte catalase and their subunits. Eur. J. Biochem., 48, 137–145 (1974).
Avkiran, M. and Marber, M. S., Na+/H+ exchange inhibitors for cardioprotective therapy: Progress, problems and prospects. J. Am. Coll. Cardiol., 39, 747–753 (2002).
Avkiran, M., Cook, A. R., and Cuello, F., Targeting Na+/H+ exchanger regulation for cardiac protection: A RSKy approach? Curr. Opin. Pharmacol., 8, 133–140 (2008).
Bhattaram, V. A., Nagaraja, N. V., Peters, T., Machnig, T., Kroesser, S., Kovar, A., and Derendorf, H., Population pharmacokinetics of eniporide and its metabolite in healthy subjects and patients with acute myocardial infarction. J. Clin. Pharmacol., 45, 631–639 (2005).
Chandrasekher, G. and Sailaja, D., Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival. Invest. Ophthalmol. Vis. Sci., 45, 3577–3588 (2004).
Condorelli, G., Drusco, A., Stassi, G., Bellacosa, A., Roncarati, R., Iaccarino, G., Russo, M. A., Gu, Y., Dalton, N., Chung, C., Latronico, M. V., Napoli, C., Sadoshima, J., Croce, C. M., and Ross, J. Jr., Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl. Acad. Sci. USA., 99, 12333–12338 (2002).
Dimitrova-Sumkovska, J., Djosic-Markovska, B., Zafirova-Roganovic, D., and Anastasovska, V., Effects of different dietary fatty acid supplements uppon lipoprotein metabolism and lipid peroxides production in hyperlipidemic rats. Prilozi., 27, 67–86 (2006).
Doggrell, S. A. and Hancox, J. C., Is timing everything? Therapeutic potential of modulators of cardiac Na+ transporters. Expert Opin. Investig. Drugs, 12, 1123–1142 (2003).
Fantinelli, J. C., Cingolani, H. E., and Mosca, S. M., Na+/H+ exchanger inhibition at the onset of reperfusion decreases myocardial infarct size: role of reactive oxygen species. Cardiovas.c Pathol., 15, 179–184 (2006).
Fliegel, L., Regulation of the Na+/H+ exchanger in the healthy and diseased myocardium. Expert. Opin. Ther. Targets, 13, 55–68 (2009).
Franke, T. F., Hornik, C. P., Segev, L., Shostak, G. A., and Sugimoto, C., PI3K/Akt and apoptosis: size matters. Oncogene, 22, 8983–8998 (2003).
Garciarena, C. D., Caldiz, C. I., Correa, M. V., Schinella, G. R., Mosca, S. M., Chiappe de Cingolani, G. E., Cingolani, H. E., and Ennis, I. L., Na+/H+ exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action. J. Appl. Physiol., 105, 1706–1713 (2008).
Goyal, S., Vanden Heuvel, G., and Aronson, P. S., Renal expression of novel Na+/H+ exchanger isoform NHE8. Am. J. Physiol. Renal Physiol., 284, F467–F473 (2003).
Green, D. R. and Reed, J. C., Mitochondria and apoptosis. Science, 281, 1309–1312 (1998).
Gross, E. R., Hsu, A. K., and Gross, G. J., Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ. Res., 94, 960–966 (2004).
Halestrap, A. P. and Brennerb, C., The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr. Med. Chem., 10, 1507–1525 (2003).
Javadov, S. A., Clarke, S., Das, M., Griffiths, E. J., Lim, K. H., and Halestrap, A. P., Ischaemic preconditioning inhibits opening of mitochondrial permeability transition pores in the reperfused rat heart. J. Physiol., 549, 513–524 (2003).
Javadov, S., Choi, A., Rajapurohitam, V., Zeidan, A., Basnakian, A. G., and Karmazyn, M., NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Cardiovasc. Res., 77, 416–424 (2008).
Jonassen, A. K., Mjos, O. D., and Sack, M. N., p70s6 kinase is a functional target of insulin activated Akt cell-survival signaling. Biochem. Biophys. Res. Commun., 315, 160–165 (2004).
Juhaszova, M., Zorov, D. B., Kim, S. H., Pepe, S., Fu, Q., Fishbein, K. W, Ziman, B. D., Wang, S., Ytrehus, K., Antos, C. L., Olson, E. N., and Sollott, S. J., Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J. Clin. Invest., 113, 1535–1549 (2004).
Jung, Y. S., Kim, M. Y., Kim, M. J., Oh, K. S., Yi, K. Y., Lee, S., Yoo, S. E., and Lee, B. H., Pharmacological profile of KR-33028, a highly selective inhibitor of Na+/H+ exchanger. Eur. J. Pharmacol., 535, 220–227 (2006).
Karmazyn, M. and Moffat, M. P., Role of Na+/H+ exchange in cardiac physiology and pathophysiology: Mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc. Res. 27, 915–924 (1993).
Karmazyn, M., Gan, X. T., Humphreys, R. A., Yoshida, H., and Kusumoto, K., The myocardial Na+-H+ exchange: structure, regulation, and its role in heart disease. Circ. Res., 85, 777–786 (1999).
Karmazyn, M., Sostaric, J. V., and Gan, X. T., The myocardial Na+/H+ exchanger: a potential therapeutic target for the prevention of myocardial ischaemic and reperfusion injury and attenuation of postinfarction heart failure. Drugs, 61, 375–389 (2001).
Karmazyn, M., Targeting the myocardial sodium-hydrogen exchange for treatment of heart failure. Expert Opin. Ther. Targets, 6, 291–298 (2002).
Kilic, A., Velic, A., De, Windt, L. J., Fabritz, L., Voss, M., Mitko, D., Zwiener, M., Baba, H. A., van Eickels, M., and Schlatter, E., Kuhn M., Enhanced activity of the myocardial Na+/H+ exchanger NHE-1 contributes to cardiac remodeling in atrial natriuretic peptide receptor-deficient mice. Circulation, 112, 2307–2317 (2005).
Kim, M. J., Moon, C. H., Kim, M. Y., Lee, S., Yi, K. Y., Yoo, S. E., Lee, S. H, Baik, E. J., and Jung, Y. S., KR-32570, a novel Na+/H+ exchanger-1 inhibitor, attenuates hypoxiainduced cell death through inhibition of intracellular Ca2+ overload and mitochondrial death pathway in H9c2 cells. Eur. J. Pharmacol., 525, 1–7 (2005).
Korge, P., Goldhaber, J. I., and Weiss, J. N., Phenylarsine oxide induces mitochondrial permeability transition, hypercontracture, and cardiac cell death. Am. J. Physiol. Heart. Circ. Physiol., 280, H2203–H2213 (2001).
Lee, B. H., Seo, H. W., Yi, K. Y., Lee, S., Lee, S., and Yoo, S. E., Effects of KR-32570, a new Na+/H+ exchanger inhibitor, on functional and metabolic impairments produced by global ischemia and reperfusion in the perfused rat heart. Eur. J. Pharmacol., 511, 175–182 (2005a).
Lee, B. H., Yi, K. Y., Lee, S., Lee, S., and Yoo, S. E., Effects of KR-32570, a new sodium hydrogen exchanger inhibitor, on myocardial infarction and arrhythmias induced by ischemia and reperfusion. Eur. J. Pharmacol., 523, 101–108 (2005b).
Lee, S., Yi, K. Y., Hwang, S. K., Lee, B. H., Yoo, S.E., and Lee, K., 2005c. (5-Arylfuran-2-ylcarbonyl)guanidines as cardioprotectives through the inhibition of Na+/H+ exchanger isoform-1. J. Med. Chem., 48, 2882–2891 (2005c).
Lee, K. S., **, Y. R., Lee, J. J., Lim, Y., Son, D. J., Lee, C. K., Yi, K. Y., Yoo, S. E., Shin, H. S., and Yun, Y. P., Antiplatelet activity of KR-32560, a novel sodium/hydrogen exchanger-1 inhibitor. Pharmacol. Res., 53, 265–270 (2006).
Leem, C. H., Lagadic-Gossmann, D., and Vaughan-Jones, R. D., Characterization of intracellular pH regulation in the guinea-pig ventricular myocyte. J. Physiol., 517, 159–180 (1999).
Marala, R. B., Brown, J. A., Kong, J. X., Tracey, W. R., Knight, D. R., Wester, R. T., Sun, D., Kennedy, S. P., Hamanaka, E. S., Ruggeri, R. B., Hill, R. J., Zoniporide: a potent and highly selective inhibitor of human Na+/H+ exchanger-1. Eur. J. Pharmacol., 451, 37–41 (2002).
Masereel, B., Pochet, L., and Laeckmann, D., An overview of inhibitors of Na+/H+ exchanger. Eur. J. Med. Chem., 38, 547–554 (2003).
Mentzer, R. M. Jr., Lasley, R. D., Jessel, A., and Karmazyn, M., Intracellular sodium hydrogen exchange inhibition and clinical myocardial protection. Ann. Thorac. Surg., 75, S700–S708 (2003).
Miura, T. and Miki, T., GSK-3beta, a therapeutic target for cardiomyocyte protection. Circ. J., 73, 1184–1192 (2009).
Ohkawa, H., Ohishi, N., and Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95, 351–358 (1979).
Orrenius, S., Zhivotovsky, B., and Nicotera, P., Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol., 4, 552–565 (2003).
Paglia, D. E. and Valentine, W. N., Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 70, 158–169 (1967).
Park, J. W., Roh, H. Y., Jung, I. S., Yun, Y. P., Yi, K.Y., Yoo, S. E., Kwon, S. H., Chung, H. J., Shin, H. S., Effects of [5-(2-methoxy-5-fluorophenyl)furan-2-ylcarbonyl]guanidine (KR-32560), a novel sodium/hydrogen exchanger-1 inhibitor, on myocardial infarct size and ventricular arrhythmias in a rat model of ischemia/reperfusion heart injury. J. Pharmacol. Sci., 98, 439–449 (2005).
Piper, H. M., Garcia-Dorado, D., and Ovize, M., A fresh look at reperfusion injury. Cardiovasc. Res., 38, 291–300 (1998).
Piper, H. M., Abdallah, Y., and Schäfer, C., The first minutes of reperfusion: A window of opportunity for cardioprotection. Cardiovasc. Res., 61, 365–371 (2004).
Rajak, S., Banerjee, S. K., Sood, S., Dinda, A. K., Gupta, Y. K., Gupta, S. K., Maulik, S. K., Emblica officinalis causes myocardial adaptation and protects against oxidative stress in ischemic-reperfusion injury in rats. Phytother. Res., 18, 54–60 (2004).
Rizzuto, R., Bernardi, P., and Pozzan, T., Mitochondria as all-round players of the calcium game. J. Physiol., 529, 37–47 (2000).
Rothstein, E. C., Byron, K. L., Reed, R. E., Fliegel, L., and Lucchesi, P. A., H2O2-induced Ca2+ overload in NRVM involves ERK1/2 MAP kinases: role for an NHE-1-dependent pathway. Am. J. Physiol. Heart. Circ. Physiol., 283, H598–H605 (2002).
Ruiz-Meana, M., Garcia-Dorado, D., Pina, P., Inserte, J., Agullo, L., and Soler-Soler, J., Cariporide preserves mitochondrial proton gradient and delays ATP depletion in cardiomyocytes during ischemic conditions. Am. J. Physiol. Heart. Circ. Physiol., 285, H999–H1006 (2003).
Scheid, M. P. and Woodgett, J. R., Unravelling the activation mechanisms of protein kinase B/Akt. FEBS. Lett., 546, 108–112 (2003).
Scholz, W., Albus, U., Counillon, L., Gogelein, H., Lang, H. J., Linz, W., Weichert, A., and Schölkens, B. A., Protective effects of HOE642, a selective sodium-hydrogen exchange subtype 1 inhibitor, on cardiac ischaemia and reperfusion. Cardiovasc. Res., 29, 260–268 (1995).
Shimada, Y., Hearse, D. J., and Avkiran, M., Impact of extracellular buffer composition on cardioprotective efficacy of Na+/H+ exchanger inhibitors. Am. J. Physiol., 270, H692–H700 (1996).
Smaili, S. S., Hsu, Y. T., Carvalho, A. C., Rosenstock, T. R., Sharpe, J. C., and Youle, R. J., Mitochondria, calcium and pro-apoptotic proteins as mediators in cell death signaling. Braz. J. Med. Biol. Res., 36, 183–190 (2003).
Snabaitis, A. K., Hearse, D.J., and Avkiran, M., Regulation of sarcolemmal Na+/H+ exchange by hydrogen peroxide in adult rat ventricular myocytes. Cardiovasc. Res., 53, 470–480 (2002).
Sun, H. Y., Wang, N. P., Halkos, M. E., Kerendi, F., Kin, H., Wang, R. X., Guyton, R. A., and Zhao, Z. Q., Involvement of Na+/H+ exchanger in hypoxia/re-oxygenation-induced neonatal rat cardiomyocyte apoptosis. Eur. J. Pharmacol., 486, 121–131 (2004).
Teshima, Y., Akao, M., Jones, S. P., and Marban, E., Cariporide (HOE642), a selective Na+/H+ exchange inhibitor, inhibits the mitochondrial death pathway. Circulation, 108, 2275–2281 (2003).
Theroux, P., Protection of the myocardial cell during ischemia. Am. J. Cardiol., 83, 3G–9G (1999).
Tsang, A., Hausenloy, D. J., Mocanu, M. M., and Yellon, D. M., Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ. Res., 95, 230–232 (2004).
Tsang, A., Hausenloy, D. J., and Yellon, D. M., Myocardial postconditioning: reperfusion injury revisited. Am. J. Physiol. Heart Circ. Physiol., 289, H2–H7 (2005).
Wagner, C., Tillack, D., Simonis, G., Strasser, R. H., and Weinbrenner, C., Ischemic post-conditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis. Mol. Cell. Biochem., 339, 135–147 (2010).
Wei, S., Rothstein, E. C., Fliegel, L., Dell’Italia, L. J., and Lucchesi, P. A., Differential MAP kinase activation and Na+/H+ exchanger phosphorylation by H(2)O(2) in rat cardiac myocytes. Am. J. Physiol. Cell Physiol., 281, C1542–1450 (2001).
Weiss, J. N., Korge, P., Honda, H. M., and **, P., Role of the mitochondrial permeability transition in myocardial disease. Circ. Res., 93, 292–301 (2003).
Wendel, A., Glutathione peroxidase. Methods Enzymol., 77, 325–333 (1981).
Woodcock, E. A., Arthur, J. F., and Matkovich, S. J., Inositol 1,4,5-trisphos-phate and reperfusion arrhythmias. Clin. Exp. Pharmacol. Physiol., 27, 734–737 (2000).
Wu, K. L., Khan, S., Lakhe-Reddy, S., Jarad, G., Mukherjee, A., Obejero-Paz, C. A., Konieczkowski, M., Sedor, J. R., and Schelling, J. R., The NHE1 Na+/H+ exchanger recruits ezrin/radixin/moesin proteins to regulate Akt-dependent cell survival. J. Biol. Chem., 279, 26280–26286 (2004).
Yin, H., Chao, L., and Chao, J., Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension, 43, 109–116 (2004).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jung, IS., Lee, SH., Yang, MK. et al. Cardioprotective effects of the novel Na+/H+ exchanger-1 inhibitor KR-32560 in a perfused rat heart model of global ischemia and reperfusion: Involvement of the Akt-GSK-3β cell survival pathway and antioxidant enzyme. Arch. Pharm. Res. 33, 1241–1251 (2010). https://doi.org/10.1007/s12272-010-0815-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-010-0815-z